SCINTIX® biology-guided radiotherapy detects and responds to signals emitted from the cancer itself and, for the first time, uses them to deliver immediate treatment for tumors in the lung or bone that may arise from primary or metastatic disease.
SELF-DRIVING RADIOTHERAPY
Cancer is talking. We’re listening.
When radiopharmaceuticals are introduced into the body, cancer cells absorb them and create a biological beacon, which our X1 platform uses to manage motion and treat solid tumors of any stage disease.
Targeting Cancer
GOOD NEWS FOR ORGANS. BAD NEWS FOR TUMORS.
Our SCINTIX technology delivers high doses of radiation to tumors, even those in motion. Live targeting allows for greater impact to the tumor and potentially less dose to surrounding tissues.
ANY STAGE TUMOR
A world where stage is just a number.
Most patients with stage four cancer are not considered candidates for definitive radiotherapy. Our breakthrough SCINTIX therapy creates a new option for patients with lung or bone tumors arising from primary or metastatic cancer.
Combination Treatment
Come at cancer from every angle.
Treating cancer isn’t a one-size-fits-all situation. For many patients, the best treatment plan is a combination of multiple therapies. Adding SCINTIX therapy to chemotherapy, immunotherapy and targeted drugs may potentially improve outcomes.
HAYWARD, Calif., Feb. 10, 2025 – RefleXion Medical, a theranostic oncology company, today announced the scheduled installation of its RefleXion® X1 platform with SCINTIX® biology-guided radiotherapy at Beverly Hills Cancer Center (BHCC), the first freestanding cancer center (FSCC) that has installed the RefleXion X1. “At BHCC, we are committed to advancing cancer care by integrating the […]
In a landscape of declining Medicare reimbursements for conventional radiotherapy over the past decade, SCINTIX® therapy stands alone as a new modality in radiation therapy that bucks the trend. In January 2024, SCINTIX therapy was granted accretive reimbursement compared to other radiotherapy modalities. The Centers for Medicare and Medicaid Services (CMS) established a national payment […]